![]() |
|
|
Vol. 281, Issue 2, 855-860, 1997
Institute of Veterinary Pharmacology (B.G., A.W., G.S.) and Department of Clinical Pharmacology (M.S.), University of Berne, 3012 Berne, Switzerland
| |
Abstract |
|---|
|
|
|---|
The synthetic pyrethroid derivatives permethrin and cyhalothrin are widely used insecticides that are considered to be relatively nontoxic to higher animals. However, a variety of toxic effects on mammals have been reported. We investigated the effect of these drugs on energy coupling by mitochondria and on the activity of the individual respiratory complexes. Using isolated rat liver mitochondria, a concentration-dependent inhibition of glutamate and succinate sustained state 3 respiration was found for both compounds in the micromolar range. The effect of pyrethroids on the activities of the complexes I to V were assessed individually in submitochondrial particles (complex I) and in freeze-thawed mitochondria (complexes II-V). Complex I (EC 1.6.5.3) was found to be the most sensitive link within the electron transport chain. Half-maximal inhibition was observed at 0.73 µM permethrin and 0.57 µM cyhalothrin, respectively, and exhibited sigmoidal inhibition kinetics. Complexes II, III, IV and V (EC 1.3.5.1, 1.10.2.2, 1.9.3.1, 3.6.1.34) were not significantly inhibited by up to 50 µM of these drugs. Thus, our results reveal a mode of action of synthetic pyrethroid insecticides not previously reported.
| |
Introduction |
|---|
|
|
|---|
Pyrethroid insecticides are
synthetic analogues of the natural pyrethrins contained in flowers of
the genus Chrysanthemum. They form, together with
chlorinated hydrocarbons (DDT, dieldrin, lindane), organo-phosphorus
compounds (parathion, malathion, diazinon) and methylcarbamate esters
(aldicarb, carbofuran, carbaryl) the four major classes of
insecticides. Pyrethroids are neurotoxins. Based on the symptomology
after acute intoxication of insects and mammals, they fall into two
classes: type I, non-
-cyano-pyrethroids, such as permethrin, show
generally peripheral activities and type II pyrethroids, such as
cyhalothrin, incline to central action (Leahey, 1985
). The latter are
characterized chemically by a cyano substituent (fig.
1).
|
Although synthetic pyrethroids are classified as well known and safe
substances (Casida et al., 1983
), their widespread use, their high, nonselective potency, and their considerable stability in
the environment make them potentially harmful. In fact, intoxications of mammals, including humans, by pyrethroids has been observed (Chen
et al., 1991
). The underlying mechanisms of these toxic effects are not known.
A number of biochemical interactions of pyrethroids have been described
in the literature. Alteration of the sodium channel kinetics is
supposed to be the principal molecular mode of action of synthetic
pyrethroids (Vijverberg et al., 1982
; Vijverberg and van den
Bercken, 1990; Tatebayashi and Narahashi, 1994
). But inhibitory effects
have also been described for Ca++-channels (Kadous et
al., 1994
), ATPases (Reddy et al., 1991
; Michelangeli
et al., 1990
), and the receptors for acetylcholine (Abbassy
et al., 1983
), GABA (Lawrence and Casida, 1983
), serotonin (Oortgiesen et al., 1989
) and benzodiazepine (Devaud and
Murray, 1988
). However, whether any of these interactions are
responsible for the toxicological effects of pyrethroids in higher
animals remains unclear. Recently, an effect of pyrethroids on
mitochondria was observed in fish exposed to these drugs in
vivo. It was found that pyrethroids affected
O2-consumption and led to a decrease in the activity of
mitochondrial enzymes (Reddy and Philip, 1992
; Ghosh, 1989
). However,
effects of pyrethroids on energy conservation by mammalian mitochondria
have never been reported. In several toxicological models, movement
disorders were linked to a dysfunction of mitochondria. Also, models
exist for the development of movement disorders, based on toxins
inhibiting complexes I and II of mitochondria (Schulz and Beal, 1994
).
In this light it appeared important to investigate the effects of
pyrethroids on the activity of respiratory chain enzymes of mammalian
mitochondria.
Here, we show that submicromolar concentrations of pyrethroids inhibit the respiratory complex I of rat liver mitochondria. This disturbance of the mitochondrial respiratory chain by pyrethroids could provide a new explanation for some of the symptoms of pyrethroid intoxication.
| |
Methods |
|---|
|
|
|---|
Materials.
Cyhalothrin,
(3-(2-chlor-3,3,3,-trifluor-1-propenyl)-2,2-demethylcyclopropanecarboxylic
acid [1
,3
(Z)]-(±)-cyano(3-phenoxyphenyl)methyl ester) and
permethrin, (m-phenoxybenzyl(RS)-cis,
trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate) from Riedel-de Haën (Seelze, Germany), were dissolved in
dimethylsulfoxide and were made fresh every day. Rotenone, horse heart
cytochrome c and antimycin A were purchased from Sigma
Chemical Co. (St. Louis, MO), threonyltrifluoroaceton,
2,6-dichlorophenolindophenol and DCCD were delivered from Fluka (Buchs,
Switzerland). Duroquinol was synthesized from duroquinone (Fluka)
according to Ragan et al. (1987)
. Crystalline suspensions in
ammonium sulfate solution of pyruvate kinase (EC2.7.1.40, 10 mg/ml)
and lactate dehydrogenase (EC1.1.1.27, 5 mg/ml) from rabbit muscle
were form Boehringer Mannheim (Mannheim, Germany). Biuret reagent
(Merkotest, Total Protein) was from Merck (Darmstadt, Germany).
Isolation of rat liver mitochondria.
Mitochondria were
isolated by differential centrifugation according to Hoppel et
al. (1979)
. Briefly, male Sprague-Dawley rats, 500 g, were
killed by decapitation and the liver was quickly removed. It was placed
in ice-cold buffer A (220 mM mannitol, 70 mM sucrose, 5 mM MOPS, pH
7.4). The liver was minced and washed with buffer A. After the addition
of 2 mM EDTA, a 10% suspension (w/v) of the minced liver was
homogenized using a Potter-Elvehjem homogenizer with a loose fitting
Teflon pestle. Nuclei and cell debris were removed by centrifugation at
700 × g for 10 min. Mitochondria were separated by
centrifugation of the supernatant at 7000 × g for 10 min. The resulting mitochondrial pellet was washed twice with buffer A
by resuspension and centrifugation as before and suspended in buffer A
to a concentration of approximately 100 mg mitochondrial protein per
ml.
Preparation of SMP.
SMP were obtained form mitochondria
according to Ragan et al. (1987)
. Freshly prepared, coupled
rat liver mitochondria were suspended at a protein concentration of 15 mg/ml in buffer B (300 mM sucrose, 5 mM MOPS, 5 mM KPi, 1 mM EGTA, pH 7.4) and sonicated with a Labsonic U sonicator (Braun,
Melsung, Germany) fitted with a microtip. Five bursts of 10 sec were
applied at 50 W and 50% duty cycle. Between bursts, the suspension was
allowed to cool. The sonicated sample was diluted with an equal volume
of buffer B and centrifuged at 15,000 × g for 10 min.
SMP were collected from the supernatant by centrifugation at
100,000 × g for 30 min. The resulting pellet was
washed twice by resuspension and centrifugation as before and suspended
in buffer B to a final concentration of 5 mg mitochondrial protein per
ml.
Oxygen electrode studies. Oxygen consumption of coupled mitochondria was measured in a chamber equipped with a Clark-type oxygen electrode (Yellow Springs Instrument Co., Yellow Springs, OH) at 30°C. The incubation medium [250 mM sucrose, 10 mM KCl, 1 mM Pi (Tris-salt), 25 mM Tris-Cl, pH 7.2] contained 0.87 ± 0.05 mg/ml mitochondrial protein. Permethrin and cyhalothrin were added to the medium 2 min before starting the reaction with 3 mM glutamate or succinate. After the recording of stable basal respiration, state 3 respiration was transiently initiated by the addition of 200 nmol ADP. In all the experiments described in this report, the concentration of DMSO never exceeded 1.5% (v/v) and controls with the same amount DMSO were always conducted. To uncouple mitochondria, 1.5 µM carbonyl cyanide p-(tri-fluoromethoxy)phenylhydrazone were added to the assay from a 1000-fold concentrated stock solution in ethanol.
Spectrophotometric assay of enzyme activities. Mitochondrial enzyme activities were determined using freeze-thawed SMP (complex I) or freeze-thawed mitochondria (complexes II-IV). The experiments were performed at 30°C. Mitochondrial preparations and pyrethroids or specific inhibitors were incubated in 3 ml medium. After an equilibration period of 5 min, the reaction was initiated by the addition of the substrate. Changes in absorbance were registered using a Perkin Elmer Corp. (Norwalk, CT) Lambda 5 UV/VIS spectrophotometer.
NADH:duroquinone oxidoreductase (EC1.6.5.3, complex I) activity was determined using 0.06 mg/ml of mitochondrial protein in 20 mM KPi, 2 mM KCN, 0.1 mM EDTA, 0.3 mM duroquinone, 0.13 mM NADH, pH 7.4 (Pecci et al., 1994Determination of protein content. Protein concentrations were determined by the Biuret Method, using bovine serum albumin as a standard.
Curve fitting.
Curves were drawn and half-maximal and
maximal inhibitory concentrations were calculated as follows. The data
on the inhibition (y) as a function of the pyrethroid concentration (p)
were fitted in a nonlinear regression analysis by applying the
Marquardt-Levenberg algorithm (Brent, 1995
) according to the Hill
equation:
|
(1) |
|
(2) |
comprises the dissociation constant of pyrethroids in the
system (Segel, 1975| |
Results |
|---|
|
|
|---|
Effect of pyrethroids on respiratory control of mitochondria.
In a first set of experiments, we looked at effects of permethrin and
cyhalothrin on the respiratory control of mitochondria by measuring the
O2-consumption. In quadruplicate assays with isolated,
coupled rat liver mitochondria from four animals (respiratory quotient
with glutamate (RQglutamate) = 4.1 ± 0.5), we
measured glutamate and succinate sustained oxygen consumption (state 4 respiration), ADP-stimulated oxygen consumption (state 3 respiration) and the P/O ratio. Although state 4 respiration and the P/O ratio were
not affected by permethrin or cyhalothrin (data not shown), state 3 respiration was inhibited by micromolar concentrations of these drugs
(fig. 2). Oxygen consumption of controls using glutamate
as the substrate was 47.8 ± 9.9 nmol·min
1·mg
1.
Half maximal inhibition occurred at [permethrin].5 = 22 µM, (max. inhibition 107%); [cyhalothrin].5 = 7 µM
(max. inhibition 72%). Uncoupled mitochondrial respiration was
similarly inhibited by cyhalothrin (not shown).
|
1·mg
1
and half maximal inhibition occurred at [permethrin].5 = 7.6 µM, (max. inhibition 100%) and [cyhalothrin].5 = 2.4 µM (max. inhibition 54%). From the observation that state 4 respiration was not affected by permethrin and cyhalothrin, we could
exclude uncoupling of oxidation and phosphorylation by the pyrethroids. However, our findings indicated that a component of mitochondrial respiration was inhibited. This inhibition was only apparent at the
increased rates of ADP-stimulated state 3 respiration or in uncoupled
mitochondria. Direct inhibition of a respiratory complex and/or the
inhibition of an accessory function such as the transport system for
glutamate could be responsible for the observed effects. To identify
possible sites of inhibition in the respiratory chain, we individually
assayed the activities of the respiratory complexes.
|
Assay of NADH:duroquinone oxidoreductase.
Complex I activity
was determined in extensively washed SMP from two animals. In these
preparations, the activity was 151 ± 18 nmol·min
1·mg
1
and was 72 ± 8% rotenone sensitive (19 experiments, SMP from two
animals). The rotenone sensitive activity of complex I was inhibited in
a concentration dependent manner by permethrin and cyhalothrin (fig.
4). According to equation 1, half maximal inhibition occurred at [permethrin].5 = 0.73 µM (max. inhibition
76%, n = 2.4) and [cyhalothrin].5 = 0.57 µM (max. inhibition 75%, n = 3.5). Thus, complex I
was substantially inhibited by micromolar concentrations of
pyrethroids.
|
Assay of succinate:2,6-dichloroindophenol
oxidoreductase.
Complex II activity was assessed in triplicates
from three animals. The activity of controls was 76 ± 11 nmol
min
1 mg
1 and was
97% inhibited by 1 mM of the complex II inhibitor
threonyltrifluoroaceton. The observed inhibition of complex II by
pyrethroids leveled off at 26% indicating it may not be a specific
effect (fig. 5). Using the Hill model, half maximal
inhibitions were calculated to be at (permethrin)0.5 = 0.5 µM (max. inhibition 26%) and (cyhalothrin)0.5 = 3 µM
(max. inhibition 36%).
|
Assay of duroquinol:ferricytochrome c
oxidoreductase.
In the assay of complex III
(bc1-complex, triplicates, three animals), the
background activity from the spontaneous oxidoreduction of
duroquinol:cytochrome c was 38% of the total activity and
was subtracted. The enzymatic activity of complex III was 66 ± 7 nmol·min
1·mg
1
for controls (three experiments) and was not affected by up to 50 µM
pyrethroids (fig. 6). The measured activity of complex
III was 98% inhibited by 10 µg/ml of antimycin A, a specific
inhibitor of complex III.
|
Assay of ferrocytochrome c:oxygen oxidoreductase.
Complex IV (cytochrome c oxidase) activity was not inhibited
by permethrin, but appeared somewhat inhibited by cyhalothrin in the
concentration range tested (fig. 7). However, the
difference between the inhibitory action of the two drugs was not
statistically significant. The measured control activity was 238 ± 14 nmol·min
1·mg
1
(triplicates, three animals) and 1.5 mM KCN, the classical inhibitor of
complex IV, blocked the activity completely.
|
Assay of ATPase.
Complex V activity was not influenced by
permethrin or cyhalothrin in the concentration range tested (fig.
8). The control activity was determined to be 205 ± 14 nmol·min
1·mg
1
and was 80% inhibited by 1 mM DCCD (triplicates, three animals). The
mitochondrial F-type ATPase consists of the polar, detachable F1 head portion and the membrane-embedded Fo
part. DCCD blocks the proton channel in the Fo-part of the
ATPase. Only in the complete structure, ATP hydrolysis is coupled to
proton flux and thus inhibited by DCCD. The high degree of inhibition
we observed with this reagent indicates that our preparation consisted
of 80% complete complex V molecules.
|
| |
Discussion |
|---|
|
|
|---|
Our study was undertaken to answer the question of whether permethrin, a type I pyrethroid, and/or cyhalothrin, a type II pyrethroid, interfered with the mitochondrial respiratory chain. We found that micromolar concentration of both compounds inhibited glutamate and succinate sustained state 3 respiration in a concentration-dependent manner. This inhibition could in principle be due to an effect of pyrethroids on an essential mitochondrial transport system and/or on a component of the respiratory chain. We identified complex I as major site of inhibition by permethrin and cyhalothrin. Complexes II to IV were not or only marginally affected by these drugs. We cannot rule out the possibility that pyrethroids have additional inhibitory effects on components accessory to the electron transport chain, such as transport systems. However, the inhibition of complex I is very pronounced and could thus be mainly responsible for the overall toxic effects of pyrethroids on mitochondria.
Mathematical analysis of the inhibition kinetics of complex I by permethrin and cyhalothrin indicated substantial cooperativity. Fitting the data with equation 1 yielded n-values of 2.4 for permethrin and 3.5 for cyhalothrin, indicating the interaction of at least three and four molecules, respectively, of inhibitor with complex I. This finding is not surprising in view of the hydrophobic nature of the pyrethroids on the one hand and the structural complexity of complex I on the other: all of the more than 40 subunits of complex I are potential targets for binding of pyrethroids.
Dysfunction of mitochondria due to exposure to toxins has been
postulated to play a key role in the pathogenesis of movement disorders
(Schulz and Beal, 1994
). Inhibition of the mitochondrial complexes I
and II (Pecci et al., 1994
; Veitch and Hue, 1994
) has drawn
particular attention in this context, as some neurotoxins are known to
interact with these sites. Model systems that use this mode of action
for the induction of neurodegenerative diseases have recently been
described. Even a slight inhibition of complex I induced concentration
dependent, cell specific apoptosis in PC12 cells (Hartley et
al., 1994
). Also, suppression of complex I activity was found to
be the ultimate step in the mode of action of MPTP. MPTP was discovered
as a contaminant of an illicit pethidine analogue by the appearance of
parkinsonian symptoms in young drug abusers. The neurotoxicity of MPTP
was subsequently found to be based on the accumulation of the
metabolite MPP+ in the mitochondrial matrix of neuronal
cells, where it inhibited complex I of the respiratory chain.
Eventually, this appears to lead to degeneration of neuronal tissue
(Tipton and Singer, 1993
). Another point in case is the induction of
insulin-dependent diabetis mellitus by intoxication with the
rodenticide Vacor. As shown recently, Vacor also inhibits complex I and
could thus lead to selective destruction of the high energy requiring
cells of pancreatic islets (Degli Esposti et al., 1996
).
Vacor and pyrethroids are in fact structurally similar chemical
compounds.
Synthetic pyrethroids are widely used in agriculture. They are
increasingly being used in veterinary applications on farm and pet
animals, for the protection of stored foodstuffs, for the control of
endemics and parasites in public health programs as well as for
household applications in kitchens and bedrooms. Specially in indoor
applications, a sustained contamination results from the adsorption of
pyrethroids to small dust particles and various other surfaces (Schwabe
et al., 1994
). Chronic exposure of unaware individuals to
low doses of synthetic pyrethroids consequently results. Synthetic
pyrethroid insecticides may therefore represent an important indoor and
environmental toxin. Based on a clinical analysis, a causative link
between the exposure to synthetic pyrethroids and the development of
motor and sensory disorders, including Parkinson-like syndromes, has
been postulated (Müller-Mohnssen and Hahn, 1995
). The result of
our study suggests a possible molecular mechanism for the clinically
observed neurotoxic symptoms after intoxication with synthetic
pyrethroid insecticides. Clearly, further studies of the inhibitory
effects of pyrethroids on mitochondria from different tissues,
particularly brain, are required to prove this point.
| |
Acknowledgments |
|---|
The authors thank Stefan Krähenbühl for helpful advice and discussion and Christine Talos for expert technical assistance.
| |
Footnotes |
|---|
Accepted for publication January 6, 1997.
Received for publication September 10, 1996.
1 This work was supported in part by Grant 3200-046804 from the Swiss National Foundation.
Send reprint requests to: Dr. Marc Solioz, Department of Clinical Pharmacology, Murtenstrasse 35, CH-3010 Berne, Switzerland.
| |
Abbreviations |
|---|
DCCD, N,N
-dicyclohexylcarbodiimide;
MOPS, 3-morpholinopropanesulfonic acid;
EDTA, ethylenediamintetraacidic acid;
EGTA, ethyleneglycol-bis-(2-aminoethyl)-tetraacetic
acid, NADH, nicotinamideadeninedinucleotide;
RQGlutamate, respiratory quotient with glutamate;
MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;
MPP+, 1-methyl-4-phenylpyridinium;
RQ, respiratory quotient, defined as the
ratio of state 3 to state 4 respiration;
DMSO, dimethylsulfoxide.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. Ratner, A. Starkov, D. Matsiukevich, R. A. Polin, and V. S. Ten Mitochondrial Dysfunction Contributes to Alveolar Developmental Arrest in Hyperoxia-Exposed Mice Am. J. Respir. Cell Mol. Biol., May 1, 2009; 40(5): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||